The recent vigorous transnational migration of people and materials re‰ecting the development of transportation facilities, changes in social structure, and war disasters has increased the global spread of emerging and re-emerging infectious diseases. Vaccine, which is the major fundamental prophylaxis against infectious diseases, has greatly contributed to the maintenance and improvement of human health worldwide. However, the disadvantages of conventional injection systems hamper the speedy mass-vaccination and the global distribution of vaccines. Transcutaneous immunization systems, which are easy-to-use and low-invasive methods of vaccination, have the potential to overcome certain issues associated with injectable vaccinations. In this review, we provide an outline of recent trends in the development of techniques for the transcutaneous delivery of vaccine antigens. We also introduce basic and clinical research involving our transcutaneous immunization systems that incorporate self-dissolving microneedle patch.
A: The microneedle of the MH series is controlable to various shapes and length. B: MH200K, MH300K, or MH800 loaded with ‰uorescein-labeled ovalbumin (F-OVA) or ‰uorescein isothiocyanate-labeled silica particles (300 nm in diameter; FITC-SP) were applied on the back skin of mice for 1 h. The skin frozen section (8-mm thick) were photographed under a ‰uorescence microscope. The nucleus was counterstained using 4′ ,6-diamidino-2-phenylindole (DAPI). The white dotted lines indicate the surfaces of the stratum corneum, epidermis, and superˆcial dermis, respectively, from top to bottom. Control groups were transcutaneously treated with MH application without HA antigen (TCI placebo group) or intramuscularly injected with 0.4 mg of HA antigen (IMI group) , twice at 4-week intervals. These mice were intranasally infected with 6×10 5 plaque-forming unit (PFU) of the A/PR/8/34 (H1N1) virus. A: At the indicated points, sera collected from these mice were assayed for the HA-speciˆc IgG titer by ELISA. B: Two weeks after theˆnal vaccination, sera collected from these mice were assayed for the hemagglutination inhibition (HI) titer. C: Body weight was measured and is presented as a percentage of the initial weight before infection (day 0) . D: Six days after infection, the lungs were collected from these mice and number of viruses in the lung homogenate was determined using a plaque assay system. Data are expressed as mean±S.E. of results from 13 (A and B) or 10 (C and D) mice. The MH800 was applied to the skin of left lateral upper arm of healthy volunteers. A: One or 6 h later, the microneedle arrays were observed under stereoscopic microscope. B: Five seconds after MH800-application, skin images were photographed under in vivo confocal scanning laser microscope. 
